Salzhauer Michael’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-9,400
| Closed | -$21K | – | 100 |
|
|
2023
Q4 | $21K | Buy |
+9,400
| New | +$284K | 0.02% | 83 |
|
|
2021
Q4 | – | Sell |
-10,800
| Closed | -$79K | – | 128 |
|
|
2021
Q3 | $79K | Buy |
10,800
+600
| +6% | +$26.6K | 0.03% | 114 |
|
|
2021
Q2 | $74K | Sell |
10,200
-4,800
| -32% | -$187K | 0.03% | 116 |
|
|
2021
Q1 | $56K | Buy |
15,000
+5,000
| +50% | +$178K | 0.03% | 111 |
|
|
2020
Q4 | $50K | Buy |
10,000
+1,568
| +19% | +$57.5K | 0.04% | 97 |
|
|
2020
Q3 | $13K | Buy |
+8,432
| New | +$296K | 0.01% | 92 |
|
|
2020
Q2 | – | Sell |
-8,432
| Closed | -$7K | – | 95 |
|
|
2020
Q1 | $7K | Hold |
8,432
| – | – | 0.01% | 105 |
|
|
2019
Q4 | $26K | Hold |
8,432
| – | – | 0.01% | 135 |
|
|
2019
Q3 | $17K | Buy |
8,432
+2,846
| +51% | +$103K | 0.01% | 132 |
|
|
2019
Q2 | $49K | Hold |
5,586
| – | – | 0.02% | 134 |
|
|
2019
Q1 | $50K | Hold |
5,586
| – | – | 0.02% | 142 |
|
|
2018
Q4 | $58K | Sell |
5,586
-4,954
| -47% | -$206K | 0.03% | 139 |
|
|
2018
Q3 | $113K | Hold |
10,540
| – | – | 0.04% | 158 |
|
|
2018
Q2 | $48K | Hold |
10,540
| – | – | 0.02% | 166 |
|
|
2018
Q1 | $44K | Hold |
10,540
| – | – | 0.02% | 162 |
|
|
2017
Q4 | $48K | Hold |
10,540
| – | – | 0.02% | 159 |
|
|
2017
Q3 | $44K | Hold |
10,540
| – | – | 0.02% | 158 |
|
|
2017
Q2 | $30K | Hold |
10,540
| – | – | 0.01% | 159 |
|
|
2017
Q1 | $36K | Hold |
10,540
| – | – | 0.02% | 159 |
|
|
2016
Q4 | $31K | Hold |
10,540
| – | – | 0.02% | 156 |
|
|
2016
Q3 | $41K | Hold |
10,540
| – | – | 0.03% | 140 |
|
|
2016
Q2 | $35K | Hold |
10,540
| – | – | 0.03% | 140 |
|
|
2016
Q1 | $26K | Hold |
10,540
| – | – | 0.02% | 145 |
|
|
2015
Q4 | $28K | Hold |
10,540
| – | – | 0.02% | 151 |
|
|
2015
Q3 | $31K | Hold |
10,540
| – | – | 0.03% | 145 |
|
|
2015
Q2 | $38K | Hold |
10,540
| – | – | 0.03% | 141 |
|
|
2015
Q1 | $44K | Hold |
10,540
| – | – | 0.04% | 131 |
|
|
2014
Q4 | $28K | Buy |
+10,540
| New | +$302K | 0.02% | 143 |
|
Other funds holding PFE
Salzhauer Michael's PFE Position: Q2 2026 in Review
Salzhauer Michael sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,135 shares — an estimated $200K sold.
Salzhauer Michael first reported a position in PFE in Q1 2015 and held it in 27 quarters. The position peaked at $264K in Q3 2018. 2,832 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Salzhauer Michael reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Salzhauer Michael sold 7,135 Pfizer shares in Q2 2026, an estimated $200K.
- Salzhauer Michael first reported a position in Pfizer in Q1 2015 and held it in 27 quarters.
- Salzhauer Michael's Pfizer position peaked at $264K in Q3 2018.
- 2,832 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Salzhauer Michael's 13F filing for Q2 2026, filed 20 Jul 2026.